Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Nicole Concin, MD, PhD, highlights key data for endometrial and ovarian cancers presented at the ESGO 2021 annual meeting, including:
Department of Gynaecology and Obstetrics
Medical University Innsbruck
Consultant in Gynaecological Oncology
Department of Gynaecology and Gynaecologocial Oncology
KEM Evang. Kliniken Essen-Mitte
This program has been made available online.
Downloadable slideset from a local live webinar developed by gynecologic oncology experts with guidance on the management of relapsed cervical cancer
Commentary from Nelson F. Sanchez, MD, on caring for transgender individuals, from the healthcare disparities they face to how healthcare professionals can improve their care, from Clinical Care Options (CCO)
Downloadable slideset updated with highlights of key gynecologic oncology studies presented at conferences throughout 2022, from Clinical Care Options (CCO)
Phase III MITO23: data on trabectedin vs investigator’s choice of chemotherapy in BRCA-mutant or BRCAness phenotype recurrent ovarian cancer, presented at ASCO 2022 and reported by Clinical Care Options (CCO)